X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39545) 39545
Newsletter (2981) 2981
Newspaper Article (2096) 2096
Book Chapter (192) 192
Magazine Article (110) 110
Transcript (44) 44
Book / eBook (40) 40
Conference Proceeding (36) 36
Dissertation (23) 23
Trade Publication Article (20) 20
Publication (17) 17
Reference (15) 15
Book Review (13) 13
Web Resource (7) 7
Government Document (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atherosclerosis (37818) 37818
humans (27068) 27068
male (16522) 16522
female (14163) 14163
middle aged (11484) 11484
risk factors (10291) 10291
animals (10239) 10239
aged (8356) 8356
inflammation (7663) 7663
cardiac & cardiovascular systems (7609) 7609
cardiovascular disease (7292) 7292
cholesterol (7140) 7140
adult (6296) 6296
research (6096) 6096
peripheral vascular disease (5613) 5613
cardiovascular diseases (5104) 5104
diabetes (4873) 4873
hypertension (4363) 4363
disease (4324) 4324
lipids (4218) 4218
risk (4170) 4170
mortality (4158) 4158
mice (4145) 4145
drug therapy (3886) 3886
pharmacology & pharmacy (3860) 3860
atherosclerosis - drug therapy (3851) 3851
care and treatment (3810) 3810
analysis (3691) 3691
cardiovascular-disease (3641) 3641
health aspects (3567) 3567
cardiovascular (3518) 3518
arteriosclerosis (3467) 3467
oxidative stress (3434) 3434
treatment outcome (3369) 3369
medical research (3280) 3280
coronary heart disease (3205) 3205
statins (3202) 3202
cardiology (3170) 3170
c-reactive protein (3059) 3059
myocardial-infarction (3016) 3016
studies (2896) 2896
prevention (2869) 2869
coronary-heart-disease (2856) 2856
medicine (2756) 2756
endocrinology & metabolism (2687) 2687
proteins (2679) 2679
medicine, experimental (2658) 2658
expression (2654) 2654
endothelium (2630) 2630
lipoproteins (2603) 2603
low density lipoproteins (2561) 2561
stroke (2524) 2524
physiological aspects (2519) 2519
biomarkers - blood (2408) 2408
medicine & public health (2396) 2396
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2340) 2340
medicine, general & internal (2308) 2308
blood pressure (2300) 2300
heart attacks (2300) 2300
research article (2278) 2278
development and progression (2237) 2237
atherosclerosis - pathology (2225) 2225
risk-factors (2219) 2219
atherosclerosis - metabolism (2208) 2208
hypercholesterolemia (2203) 2203
biochemistry & molecular biology (2191) 2191
medicine, research & experimental (2175) 2175
metabolism (2138) 2138
patients (2133) 2133
coronary vessels (2095) 2095
coronary artery disease (2047) 2047
disease models, animal (2045) 2045
prospective studies (2045) 2045
low-density-lipoprotein (2044) 2044
time factors (2044) 2044
therapy (2024) 2024
abridged index medicus (1992) 1992
aged, 80 and over (1963) 1963
association (1931) 1931
metabolic syndrome (1924) 1924
coronary-artery-disease (1887) 1887
cholesterol, ldl - blood (1882) 1882
cell biology (1879) 1879
macrophages (1858) 1858
lipids - blood (1855) 1855
heart-disease (1844) 1844
rats (1835) 1835
intima-media thickness (1829) 1829
multidisciplinary sciences (1821) 1821
cholesterol - blood (1814) 1814
internal medicine (1796) 1796
atherosclerosis - prevention & control (1795) 1795
clinical trials (1748) 1748
rodents (1746) 1746
insulin resistance (1741) 1741
diabetes mellitus (1732) 1732
cytokines (1712) 1712
hematology (1710) 1710
gene expression (1708) 1708
risk assessment (1707) 1707
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44360) 44360
Japanese (216) 216
Russian (191) 191
German (157) 157
Chinese (132) 132
Spanish (126) 126
French (114) 114
Polish (47) 47
Portuguese (33) 33
Italian (21) 21
Hungarian (16) 16
Turkish (16) 16
Czech (15) 15
Swedish (10) 10
Ukrainian (6) 6
Romanian (5) 5
Croatian (4) 4
Dutch (3) 3
Korean (3) 3
Danish (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 12, pp. 1119 - 1131
... subsequently found that beneficial outcomes after statin therapy relate to both a reduction in cholesterol level and inflammation inhibition. 7 – 11 Yet, to date... 
no | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 01/2007, Volume 13, Issue 3, pp. 333 - 346
.... In that time, many drugs have been developed but none have successfully passed clinical trials... 
Cardiovascular disease | Inflammation | Topical | Acute therapy | Remodeling | SMOKE-INDUCED EMPHYSEMA | cardiovascular disease | remodeling | topical | ABDOMINAL AORTIC-ANEURYSMS | HEART-FAILURE | BLOOD-BRAIN-BARRIER | RESPIRATORY-DISTRESS-SYNDROME | MUSCLE-CELL-MIGRATION | OBSTRUCTIVE PULMONARY-DISEASE | TISSUE-PLASMINOGEN-ACTIVATOR | inflammation | acute therapy | MACROPHAGE ELASTASE MMP-12 | PHARMACOLOGY & PHARMACY | PREVENTS CARDIAC RUPTURE | Hypertrophy, Left Ventricular - enzymology | Humans | Eye Diseases - enzymology | Protease Inhibitors - pharmacology | Atherosclerosis - enzymology | Drug Design | Hypertrophy, Left Ventricular - drug therapy | Protease Inhibitors - therapeutic use | Vascular Diseases - drug therapy | Extracellular Matrix Proteins - metabolism | Myocardial Infarction - enzymology | Atherosclerosis - drug therapy | Heart Rupture, Post-Infarction - enzymology | Neoplasms - enzymology | Skin Diseases - drug therapy | Stroke - drug therapy | Respiratory Distress Syndrome, Adult - drug therapy | Vascular Diseases - enzymology | Arthritis - enzymology | Neoplasms - drug therapy | Pulmonary Disease, Chronic Obstructive - enzymology | Stroke - enzymology | Animals | Myocardial Infarction - drug therapy | Eye Diseases - drug therapy | Arthritis - drug therapy | Matrix Metalloproteinase Inhibitors | Matrix Metalloproteinases - metabolism | Heart Rupture, Post-Infarction - drug therapy | Respiratory Distress Syndrome, Adult - enzymology | Skin Diseases - enzymology | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Cell, ISSN 0092-8674, 10/2016, Volume 167, Issue 3, pp. 843 - 857.e14
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2013, Volume 339, Issue 6116, pp. 166 - 172
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 18, pp. 2278 - 2289
... through the action of a molecular assembly known as the inflammasome. Clinically applicable interventions that interfere with IL-1 action can improve cardiovascular outcomes, ushering in a new era of anti-inflammatory therapies for atherosclerosis... 
high-sensitivity C-reactive protein | interleukin-1 | acute coronary syndromes | myocardial infarction | C-REACTIVE PROTEIN | ELEMENT-BINDING PROTEIN-2 | CARDIAC & CARDIOVASCULAR SYSTEMS | VASCULAR SMOOTH-MUSCLE | RECEPTOR ANTAGONIST | ENDOTHELIAL-CELLS | ACUTE MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | GENE-EXPRESSION | BLOCKING INTERLEUKIN-1 | Atherosclerosis - blood | Animals | Atherosclerosis - drug therapy | Humans | Anti-Inflammatory Agents - administration & dosage | Biomarkers - blood | Drug Delivery Systems - trends | Anti-Inflammatory Agents - metabolism | Drug Delivery Systems - methods | Interleukin-1beta - antagonists & inhibitors | Interleukin-1beta - blood | Medical colleges | Interleukins | Cardiac patients | Therapeutics | Atherosclerosis | Health aspects | Coronary heart disease | Cardiovascular agents | Homeopathy | Materia medica and therapeutics | Therapy | Atherogenesis | Heart attacks | Pathogenesis | Interleukin | Smooth muscle | Leukocytes | Inflammatory diseases | Risk factors | Cell adhesion & migration | Proteins | Interleukin 1 | Tumor necrosis factor-TNF | Enzymes | Cytokines | Complications | Inflammation | Risk analysis | Gene expression | Arteriosclerosis | Biomarkers | Mutation | Cardiovascular diseases | Cancer
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article